![Samuel Hopkins](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Samuel Hopkins
No más puestos en curso
Historial de carrera de Samuel Hopkins
Antiguos cargos conocidos de Samuel Hopkins.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Trimeris, Inc.
![]() Trimeris, Inc. Pharmaceuticals: MajorHealth Technology Trimeris, Inc. develops therapeutics for viral diseases. It is a biopharmaceutical company engaged in the discovery, development and commercialization of novel therapeutic agents for the treatment of viral disease. The core technology platform of fusion inhibition is based on blocking viral entry into host cells. The company was founded in 1993 and is headquartered in Durham, NC. | Director Técnico/Científico/I+D | 01/01/2001 | 01/01/2001 |
Parion Sciences, Inc.
![]() Parion Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Parion Sciences operates as a development-stage pharmaceutical company focused on the discovery and development of new treatments for serious diseases in multiple therapeutic areas. The firm's technology corrects defects in the innate defense of mucosal surfaces by developing inhibitors of the epithelial sodium channel (ENaC). The company was founded by Richard C. Boucher and is headquartered in Durham, NC. | Director Técnico/Científico/I+D | - | - |
SCYNEXIS, INC. | Director Técnico/Científico/I+D | 23/10/2009 | - |
Formación de Samuel Hopkins.
Western University of Health Sciences | Undergraduate Degree |
Medical College of Virginia | Doctorate Degree |
Estadísticas
Internacional
Estados Unidos | 6 |
Operativa
Chief Tech/Sci/R&D Officer | 3 |
Undergraduate Degree | 1 |
Doctorate Degree | 1 |
Sectorial
Health Technology | 3 |
Consumer Services | 3 |
Commercial Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
SCYNEXIS, INC. | Health Technology |
Empresas privadas | 2 |
---|---|
Parion Sciences, Inc.
![]() Parion Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Parion Sciences operates as a development-stage pharmaceutical company focused on the discovery and development of new treatments for serious diseases in multiple therapeutic areas. The firm's technology corrects defects in the innate defense of mucosal surfaces by developing inhibitors of the epithelial sodium channel (ENaC). The company was founded by Richard C. Boucher and is headquartered in Durham, NC. | Commercial Services |
Trimeris, Inc.
![]() Trimeris, Inc. Pharmaceuticals: MajorHealth Technology Trimeris, Inc. develops therapeutics for viral diseases. It is a biopharmaceutical company engaged in the discovery, development and commercialization of novel therapeutic agents for the treatment of viral disease. The core technology platform of fusion inhibition is based on blocking viral entry into host cells. The company was founded in 1993 and is headquartered in Durham, NC. | Health Technology |
- Bolsa de valores
- Insiders
- Samuel Hopkins
- Experiencia